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Abstract
Decreased bioavailability of nitric oxide (NO) is a major contributor to the pathophysiology
of severe falciparum malaria. Tetrahydrobiopterin (BH4) is an enzyme cofactor required for
NO synthesis from L-arginine. We hypothesized that systemic levels of BH4 would be de-
creased in children with cerebral malaria, contributing to low NO bioavailability. In an obser-
vational study in Tanzania, we measured urine levels of biopterin in its various redox states
(fully reduced [BH4] and the oxidized metabolites, dihydrobiopterin [BH2] and biopterin [B0])
in children with uncomplicated malaria (UM, n = 55), cerebral malaria (CM, n = 45), non-ma-
laria central nervous system conditions (NMC, n = 48), and in 111 healthy controls (HC).
Median urine BH4 concentration in CM (1.10 [IQR:0.55–2.18] μmol/mmol creatinine) was
significantly lower compared to each of the other three groups— UM (2.10 [IQR:1.32–3.14];
p<0.001), NMC (1.52 [IQR:1.01–2.71];p = 0.002), and HC (1.60 [IQR:1.15–2.23];p =
0.005). Oxidized biopterins were increased, and the BH4:BH2 ratio markedly decreased in
CM. In a multivariate logistic regression model, each Log10-unit decrease in urine BH4 was
independently associated with a 3.85-fold (95% CI:1.89–7.61) increase in odds of CM
(p<0.001). Low systemic BH4 levels and increased oxidized biopterins contribute to the low
NO bioavailability observed in CM. Adjunctive therapy to regenerate BH4 may have a role
in improving NO bioavailability and microvascular perfusion in severe falciparum malaria.
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Author Summary
Vascular nitric oxide (NO) bioavailability is decreased in severe falciparum malaria and
associated with microvascular dysfunction, increased activation of the cells lining blood
vessels (endothelial cells) and increased parasite biomass. Tetrahydrobiopterin (BH4) is an
essential cofactor for nitric oxide synthase (NOS) enzymatic conversion of L-arginine to
NO and L-citrulline. But when BH4 is low, NOS is “uncoupled” and produces superoxide
instead of NO. In oxidative conditions, BH4 is oxidized to dihydrobiopterin (BH2) and
biopterin (B0). BH2 competes with remaining BH4 at its NOS binding site, further decreas-
ing NOS-catalyzed NO production. We measured BH4, BH2 and B0 in the urine of chil-
dren with coma due to falciparum malaria (cerebral malaria), uncomplicated falciparum
malaria, children with non-malaria central nervous system conditions and healthy con-
trols. Urine BH4 was significantly decreased and BH2 significantly increased in cerebral
malaria compared to uncomplicated malaria, non-malaria central nervous conditions and
healthy controls, suggesting increased oxidative stress and insufficient recycling of BH2
back to BH4. Urine BH4 concentration was independently associated with increased risk of
cerebral malaria. Given that safe therapies for regenerating BH4 have been studied in
chronic vascular disease, this finding of low BH4 in pediatric cerebral malaria offers a new
area of investigation for adjunctive therapies aimed at improving NO bioavailability and,
consequently, clinical outcomes in severe falciparum malaria.
Introduction
Falciparum malaria causes over 600,000 deaths worldwide each year, with approximately
560,000 fatal cases annually among children in sub-Saharan Africa [1]. Coma in malaria, cere-
bral malaria (CM), portends a grave outcome among children infected with Plasmodium falcip-
arum and, despite advances in anti-parasitic drug therapies, still has a 10–20% case fatality rate
[2–4]. However, the pathogenesis of CM remains poorly understood [5]. CM pathogenesis
studies to date show endothelial dysfunction [6], endothelial activation [7–10] and cytoadher-
ence of parasitized red blood cell (pRBC) to endothelial cells in post-capillary venules, resulting
in red blood cell sequestration [11–13], microvascular congestion and impaired blood flow to
tissues [14–16]. Metabolic derangements and cytotoxic mechanisms contributing to the patho-
genesis of CM have also been proposed [5,17–19].
Low nitric oxide (NO) is a key cause and contributor to the microvascular pathophysiology
observed in severe malaria [20]. A variety of causes for low bioavailability in malaria have been
identified within multiple steps of the NO production pathway [21–23], from low levels of NO
synthase (NOS) substrate, arginine [24], to elevated levels of endogenous NOS inhibitors
[25,26]. All NOS isoforms require the obligate cofactor tetrahydrobiopterin (BH4) to enzymati-
cally generate NO from L-arginine. The role of this NOS cofactor as a potential contributor to
low NO bioavailability in malaria is unknown. In vascular diseases, low BH4 and increased con-
centrations of its oxidized metabolite, dihydrobiopterin (BH2), are not only associated with im-
paired NO synthesis, but also linked to generation of reactive oxygen species within the
endothelium [27].
In addition to its role in NO synthesis and endothelial function, BH4 is also an essential co-
factor for monooxygenase enzymes required for phenylalanine metabolism (phenylalanine hy-
droxylase [PAH]) as well as biogenic amine neurotransmitter synthesis of catecholamines
(tyrosine hydroxylase) and serotonin (tryptophan hydroxylase) [28,29]. (The reader is directed
to references 28 and 29 for reviews of BH4 metabolism, which include diagrams of BH4
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synthetic and salvage pathways.) We have previously reported elevated plasma phenylalanine
in children with CM [18]. This finding is likely attributable to impaired activity of hepatic
PAH, which regulates plasma phenylalanine levels within a narrow range by controlling the
rate of conversion of phenylalanine to tyrosine [30]. We hypothesized that hyperphenylalani-
nemia is an indicator of systemic BH4 deficiency and that BH4 deficiency would also contribute
to impaired NO bioavailability observed in malaria.
To address this hypothesis we quantified BH4 and its oxidized metabolites in urine as a mea-
sure of systemic biopterin availability [28,31–33] in children presenting with CM. Quantifying
biopterins in urine requires specific collection methods. With ordinary urine collection and
storage, BH4 spontaneously oxidizes to its metabolites, BH2 and, to a lesser extent, fully oxi-
dized biopterin (B0) [34,35]. By collecting urine directly into an anti-oxidant/chelator cocktail
in the dark followed by immediate freezing and storage at -80°C until analysis, we overcame
this potential artifact of ex vivo spontaneous oxidation. This established collection method for
biopterin analysis enabled quantification of BH4 in its reduced in vivo state [35]. In this report,
we provide quantitative data on urinary excretion of the active NOS cofactor BH4, as well as
BH2 and B0, in children at the time of presentation with CM. We found decreased levels of
BH4 and increased levels of oxidized biopterins in children with CM, indicating a marked re-
duction in BH4 bioavailability in severe malaria. Based on these findings, we propose a patho-
genic mechanism wherein low systemic BH4 contributes to low NO bioavailability and
endothelial dysfunction in severe malaria.
Results
Clinical variables describing the clinical groups
From November 2007 to January 2012 we screened 528 children for enrollment into one of
four study groups. After exclusions, 66 children with uncomplicated malaria (UM), 52 with ce-
rebral malaria (CM), 53 with non-malaria central nervous system conditions (NMC), and 116
healthy controls (HC) were enrolled (Fig. 1). Baseline characteristics comparing the four
groups are shown in Table 1. Children with CM were significantly older than children from
the other groups when compared across all groups and in pairwise comparisons between
groups. Two children with CM and one child with NMC had overt renal failure as evidenced
by plasma creatinine measurements of 2.7, 5.1, and 2.5 mg/dL, respectively. Children with CM
had significantly lower peripheral blood parasitemia, but significantly higher plasma P. falcipa-
rum histidine-rich protein-2 (PfHRP-2) concentrations compared to children with UM. To as-
sess biopterin status in CM compared to other infectious and non-infectious central nervous
system (CNS) conditions, we enrolled a comparison group comprised of children presenting to
the hospital with NMC for which lumbar puncture was clinically indicated. The NMC group
proved to be heterogeneous as expected. Clinical and laboratory investigations indicated that at
least 10 of the 53 children with NMC suffered from bacterial or fungal meningitis. No evidence
for viral encephalitis, trauma, subarachnoid hemorrhage or metabolic encephalopathy was
found. Toxic encephalopathy was possible in one child. Idiopathic seizures and aseptic menin-
gitis were other possible diagnostic categories. Seven children with CM and six children with
NMC died while hospitalized. All children with UM recovered.
Abnormal distribution of urine biopterins in children with cerebral malaria
Urine pterin concentrations differed significantly across the four groups (Table 2). Compared
to HC (n = 111), total biopterin levels (BH4 + BH2 + B0) were increased in UM (n = 55)
(p<0.001), CM (n = 45) (p<0.001), and NMC (n = 48) (p<0.001) (Fig. 2, panel A). Urine
BH4 concentrations were significantly lower in CM than in each of the other three groups
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(p0.005 for all pairwise comparisons) (Fig. 2, panel B). The statistical significance persisted
in a linear regression model to control for plasma creatinine (p = 0.021) and in a linear regres-
sion model to control for age, weight, gender and plasma creatinine (p = 0.038). Using logistic
regression, we found no significant co-variation of urine BH4 by presence or absence of pyuria
(OR 1.21 [0.65–2.25]; p = 0.56) or by presence or absence of bacteriuria (OR 0.70 [0.34–1.46];
p = 0.34). Urine BH2 was significantly higher in CM compared to each of the other three
groups (p<0.05 for all comparisons). Urine BH4 values differed significantly when compared
across UM (2.10 [IQR 1.32–3.14]), CM survivors (1.10 [IQR 0.48–2.25] μmol/mmol creati-
nine) and CM fatalities (1.02 [IQR 0.77–2.09] μmol/mmol creatinine) (p<0.001).
NOS activity is affected not only by the availability of the cofactor BH4, but also by the stoi-
chiometric balance of BH4 relative to its major oxidized metabolite BH2. BH2 competes with
BH4 at the NOS binding site and can directly inhibit NOS activity [36]. The BH4:BH2 ratio has
been proposed as the critical determinant of NO synthesis by endothelial NOS (eNOS) [37].
Accordingly, we analyzed this ratio in the four clinical groups enrolled. The BH4:BH2 ratio was
significantly lower in CM compared to each of the other groups (p<0.001 for all comparisons)
(Fig. 2, panel C). In our a priori analytical plan, we also compared the ratio of reduced to oxi-
dized biopterins (BH4: BH2+B0) and the proportion of total biopterins as BH4 (BH4/ BH4+
Fig 1. Study flow diagram. Screening, enrollment and post-hoc exclusions for the four clinical groups are depicted. CNS = central nervous system; BCS =
Blantyre Coma Score; RDT = rapid diagnostic test for P. falciparum (ParacheckPf, Omega Diagnostics); LP = lumbar puncture; SAE = serious adverse event;
CSF = cerebrospinal fluid.
doi:10.1371/journal.ppat.1004655.g001
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BH2+ B0). Using these alternative renderings to examine reduced to oxidized biopterins, we
found the same statistical relationships between CM in pairwise comparison to the other three
clinical groups (Table 2).
Compared to children with likely bacterial or cryptococcal meningitis (n = 10), children
with cerebral malaria had lower BH4 than this subset of NMC children (1.10 [IQR 0.55–2.18]
vs. 1.63 [IQR 1.39–2.90] μmol/mmol creatinine; p = 0.06), significantly higher BH2 than chil-
dren in this subset (2.24 [IQR 1.55–2.89] vs. 1.50 [IQR 0.93–2.27] μmol/mmol creatinine; p =
0.05), and a significantly lower BH4:BH2 ratio than children with likely bacterial or cryptococ-
cal meningitis (0.45 [0.21–1.13] vs. 1.35 [IQR 0.70–3.21]; p = 0.002).
Collectively, these measurements of urine biopterins demonstrate deficiency in systemic
BH4 in CM.
Elevated urine neopterins in cerebral malaria
Guanosine triphosphate cyclohydrolase I (GTPCH-1) is the rate-limiting enzyme in the first
step for BH4 de novo synthesis. Mononuclear phagocytes activated by pro-inflammatory cyto-
kines (e.g., INF-γ, TNF-α) show enhanced transcription of the GTPCH-1 gene, GCH1 [38].
However, the activity of the second enzyme for biopterin synthesis, 6-pyruvoyl
Table 1. Baseline characteristics of the 4 clinical groups.
Variable Healthy Controls
(n = 116)
Uncomplicated Malaria
(n = 66)
Cerebral Malaria
(n = 52)
Non-Malaria CNS
Conditions (n = 53)
p-
value
Age, months 34 (31–38) 44 (39–49) 51 (47–55) 29 (23–34) <0.001
Male sex, no. (%) 65 (56.5) 35 (53.0) 34 (65.4) 29 (55.8) 0.556A
Weight, kg 12.9 (12.2–13.6) 14.3 (13.4–15.2) 15.4 (14.4–16.4) 11.3 (10.3–12.3) <0.001
Axillary temperature,°C 36.7 (36.6–36.7) 39 (38.8–39.3) 38.3 (38.0–38.6) 37.7 (37.4–38.1) <0.001
Respiratory rate 32 (31–33) 36 (34–38) 43 (40–47) 37 (34–41) <0.001
Last meal, hours 3.2 (2.9–3.6) 5.9 (4.7–7.1) 5.9 (4.1–7.7) 3.8 (2.6–4.9) <0.001
Hemoglobin, g/dL 10.8 (10.4–11.1) 8.4 (7.8–9.0) 7.0 (6.5–7.5) 9.8 (9.3–10.3) <0.001
Blood glucose, mg/dLC N/D 119 (96–143) 119 (105–132) 119 (93–147) 0.996
Plasma bicarbonate, mmol/LC N/D 19.1 (16.1–22.1) 20 (18.8–21.3) 19 (17–21) 0.678
Plasma creatinine, mg/dLC N/D 0.3 (0.3–0.4) 0.8 (0.5–1.0) 0.5 (0.4–0.7) 0.031
Urine leukocyte esterase present, no. (%)D 3 (5.8) 7 (19.4) 4 (8.5) 2 (4.3) 0.08A
Plasmodium falciparum parasite density, x
103/ μL; median (interquartile range)
0 87,055 (30,115–
209,550)
45,231 (9396–
128,231)
0 0.026B
Plasma PfHRP-2, ng/mL; median
(interquartile range)
0 517.4 (39.3–1536.0) 1,086.5 (379.1–
2,585.5)
0 0.011B
Data mean (95% conﬁdence interval values) unless otherwise indicated.
ANOVA with Bonferroni post-estimate unless otherwise indicated.
A = Chi-squared,
B = Wilcoxon Rank Sum.
PfHRP-2 = Plasmodium falciparum histidine-rich protein-2.
N/D = Test not done.
C = We were unable to obtain measurements of all analytes for all patients enrolled.
Glucose measurements were obtained in 27, 48 and 43 of the UM, CM and NMC children, respectively.
Bicarbonate results were obtained 31, 48 and 47 of the UM, CM, and NMC children, respectively. Creatinine results were obtained in 16, 39 and 40 of the
UM, CM and NMC children, respectively.
D = Three children (1 HC, 1 UM and 1 CM) with bacteriuria remained in the study as the urine was collected by bag collection (i.e., not collected via sterile,
invasive procedures), and there was no clinical suspicion of urinary tract infection in any of the three subjects.
doi:10.1371/journal.ppat.1004655.t001
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tetrahydropterin synthase (PTPS), is constitutively very low in these cells and is unresponsive
to cytokine-induced transcription activation [28,39,40]. The result is shunting of the GTPCH-
1 product, 7,8 dihydroneopterin triphosphate, to neopterin end products—dihydrobiopterin
(NH2) and its oxidized metabolite, neopterin (N0) [41]. These neopterin end products accumu-
late within mononuclear phagocytes and then exit the cells to be excreted in urine. Although
the biological function of the neopterins remains obscure, elevated total urine neopterin (NH2
+ N0) is established as a marker of the cell-mediated immune response in a variety of inflam-
matory states [42]. NH2 measurement relies upon oxidation of NH2 to the naturally fluorescent
N0 in vitro for quantification [43]. We took advantage of our collection method for preserving
urine neopterins in their in vivo reduced (NH2) and oxidized (N0) states to quantify them in
CM. In doing so, we sought to determine whether the neopterins, like the biopterins, have a
redox ratio skewed towards oxidation in children with CM.
Concentrations of urine neopterin metabolites differed significantly across the four groups
(Table 2). Compared to HC, total neopterin (NH2 + N0) levels were increased in UM, CM and
NMC (p<0.001 for all comparisons) (Fig. 3, panel A). Total neopterin levels did not differ sig-
nificantly in UM compared to CM (p = 0.113). The ratio of reduced to oxidized neopterins
(NH2:N0) was significantly decreased in CM compared to UM (p = 0.001) and HC (p = 0.017).
This ratio did not statistically differ between CM and NMC (p = 0.069) (Fig. 3, panel B). The
reduced to oxidized ratio for neopterins correlated with the reduced to oxidized ratio for biop-
terins (BH4: BH2+B0) (r = 0.28, p<0.001) and oxidized neopterin (N0) correlated with oxi-
dized biopterin (BH2) (r = 0.63, p<0.001). We conclude from these measurements that while
Table 2. Urine pterins and plasma phenylalanine measurements at enrollment in the 4 clinical groups.
Variable Healthy Controls (n =
111)
Uncomplicated Malaria (n =
55)
Cerebral Malaria (n =
45)
Non-Malaria CNS Conditions
(n = 48)
p-
value
BH4
A,B,C 1.60 (1.15–2.23) 2.10 (1.32–3.14) 1.10 (0.55–2.18) 1.52 (1.01–2.71) <0.001
BH2
A,B,C 0.96 (0.75–1.33) 1.60 (0.95–2.98) 2.24 (1.55–2.89) 1.83 (1.13–2.30) <0.001
BiopterinA 0.09 (0.05–0.16) 0.24 (0.12–0.52) 0.22 (0.08–0.37) 0.13 (0.08–0.30) <0.001
Total BiopterinsA 2.82 (2.19–3.67) 4.03 (2.77–5.79) 3.83 (2.95–4.85) 3.97 (2.91–5.57) <0.001
BH4/BH2 Ratio
A,B,C 1.64 (1.21–2.18) 1.42 (0.75–1.98) 0.45 (0.21–1.13) 1.25 (0.63–2.09) <0.001
BH4/(BH2+B0)
A,B,C 1.52 (1.04–1.97) 1.17 (0.68–1.85) 0.39 (0.19–1.06) 1.12 (0.54–1.93) <0.001
BH4/Total
BiopterinsA,B,C
0.60 (0.51–0.66) 0.54 (0.40–0.65) 0.28 (0.16–0.51) 0.53 (0.35–0.66) <0.001
NH2
A,B 3.20 (1.98–4.69) 18.36 (11.62–24.37) 19.86 (15.86–23.22) 6.62 (3.69–11.77) <0.001
N0
A,B,C 0.74 (0.52–1.16) 3.93 (2.26–3.07) 5.48 (4.11–6.43) 1.43 (0.88–3.07) <0.001
Total NeopterinA,B 3.89 (2.55–5.90) 22.39 (14.02–32.22) 25.26 (20.21–30.58) 7.96 (4.53–14.85) <0.001
NH2/N0 Ratio
A,C 4.39 (3.26–5.52) 4.72 (3.52–5.57) 3.74 (3.22–4.22) 5.19 (2.83–9.61) 0.018
PhenylalanineA,B,D 53 (45–60) 101 (80–165) 129.5 (91–208) 75 (63–114) <0.001
Units: urine pterins μmol/mmol creatinine; amino acid μM.
Median and inter-quartile ranges, p-value Kruskal-Wallis comparison across all 4 groups. BH4 = tetrahydrobiopterin, BH2 = dihydrobiopterin, B0 =
biopterin, NH2 = dihydroneopterin, N0 = neopterin.
A = p-value <0.05 by Wilcoxon Rank Sum comparison between cerebral malaria and healthy controls
B = p-value < 0.05 by Wilcoxon Rank Sum comparison between cerebral malaria and non-malaria CNS condition
C = p-value < 0.05 by Wilcoxon Rank Sum comparison between cerebral malaria and uncomplicated malaria
D = Number of plasma samples for healthy controls, uncomplicated malaria, cerebral malaria and non-malaria CNS conditions was 109, 61, 50, and
51, respectively.
doi:10.1371/journal.ppat.1004655.t002
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total urine neopterin levels did not differ in CM compared to UM, quantifying neopterins in
their reduced to oxidized states may indicate oxidative stress in CM compared to UM.
Fig 2. Urine biopterin concentrations at enrollment in the 4 clinical groups. A: Comparison of total urine
biopterins (tetrahydrobiopterin [BH4] + dihydrobiopterin [BH2] + biopterin [B0]) concentrations at enrollment
for healthy controls (HC, n = 111), uncomplicated malaria (UM, n = 55), cerebral malaria (CM, n = 45) and
non-malaria central nervous system conditions (NMC, n = 48) (p<0.001 by Kruskal-Wallis). B: urine
tetrahydrobiopterin (BH4) concentrations at enrollment for all 4 groups (p<0.001 by Kruskal-Wallis). Central
line indicates median. Upper and lower lines indicate inter-quartile range.C: Comparison of urine
tetrahydrobiopterin to dihydrobiopterin (BH4:BH2) ratio at enrollment for all 4 groups (p<0.001 by Kruskal-
Wallis). The number of subjects with a sample measured in [B] and [C] is the same as Noted above in [A].
The central line indicates median. Upper and lower lines indicate interquartile range.
doi:10.1371/journal.ppat.1004655.g002
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Fig 3. Urine neopterin concentrations at enrollment in the 4 clinical groups. A: Comparison of total urine
neopterins, dihydroneopterin plus neopterin (NH2 + N0), concentrations at enrollment for healthy controls
(HC, n = 111), uncomplicated malaria (UM, n = 55), cerebral malaria (CM, n = 45) and non-malaria central
nervous system conditions (NMC, n = 48) (p<0.001 by Kruskal-Wallis). The central line indicates median.
Upper and lower lines indicate inter-quartile range.B: Comparison of urine dihydroneopterin to neopterin
(NH2:N0) at enrollment for all 4 groups (p = 0.018 by Kruskal-Wallis). The number of subjects with a sample
measured is the same as noted above in [A]. The central line indicates median. Upper and lower lines
indicate inter-quartile range.
doi:10.1371/journal.ppat.1004655.g003
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Elevated angiopoietin-2 in cerebral malaria
Angiopoietin-2 (Ang-2) is a ligand released from endothelial Weibel-Palade bodies that acts as
an autocrine mediator of endothelial activation [44], including up-regulation of intercellular
adhesion molecule (ICAM) receptors on endothelial cells [45]. Ang-2 plasma levels correlate
with clinical severity in pediatric sepsis [10,46] and are independently associated with mortality
in severe malaria [10,46,47]. NO is a known inhibitor of endothelial Weibel-Palade bodies exo-
cytosis [48]. In vitro endothelial cell experiments demonstrate biopterin redox status impacts
endothelial dysfunction [37], but it is unknown whether whole body stores of biopterins corre-
late with in vivo circulating NO-dependent mediators of endothelial activation. To assess for
associations between systemic biopterin status and endothelial activation we measured Ang-2
in a subset of randomly selected children enrolled as HC (n = 9), UM (n = 10), CM (n = 16),
and NMC (n = 9). Plasma Ang-2 concentration differed significantly across the four groups
(Fig. 4)—HC (815 [IQR 345–1264] pg/mL), UM (1882 [IQR 1035–4693] pg/mL), CM (3445
(IQR 2014–7534 pg/mL), and NMC (1149 [691–1616] pg/mL) (p<0.001). Pairwise compari-
sons among groups showed that median plasma Ang-2 levels were higher in CM compared to
HC (p<0.001), UM (p = 0.082) and NMC (p = 0.006). Correlations between plasma Ang-2
and urine biopterin metabolites were assessed within each clinical group and no significant
correlations were noted. A correlation scatterplot of plasma Ang-2 and urine BH2 values does
visually demonstrate a non-significant correlation (S1 Fig.), indicating that the small sample
size may have limited our ability to establish a significant correlation. We conclude that Ang-2
is significantly elevated in severe pediatric falciparum malaria, but we were unable to demon-
strate a correlation between Ang-2 and urine biopterin metabolites, possibly due to small
sample size.
Peripheral blood mononuclear cell mRNA for guanosine triphosphate
cyclohydrolase I in children with malaria
To determine if the low urine levels of BH4 observed in CM could in part be explained by de-
creased GCH1 expression for GTPCH-1, the rate-limiting enzyme in pterin biosynthesis [29],
we measured GCH1mRNA in peripheral blood mononuclear cells (PBMC) isolated from a
randomly selected sub-set of children enrolled as HC (n = 5), UM (n = 8) and CM (n = 9).
GCH1mRNA transcription was at least as high in each malaria group [UM (1.35 [IQR 1.11–
1.97] 2-ddCt) and CM (1.39 [IQR 0.88–1.77] 2-ddCt)] relative to controls (0.82 [IQR 0.60–0.84]
2-ddCt) (p = 0.082). We also measured GCH1mRNA in children enrolled into a separate cohort
using the same inclusion/exclusion criteria as HC (n = 33) and as CM (n = 9). Combining the
measurements from both cohorts [HC n = 38 and CM n = 18], we found no significant differ-
ence in GCH1mRNA between these two groups. We conclude that PBMC GCH1mRNA and
pterin synthesis is not decreased in children with malaria and does not account for the lower
BH4.
Hyperphenylalaninemia in children with uncomplicated malaria and
cerebral malaria
Wemeasured plasma phenylalanine in all 4 clinical groups to confirm our previous observa-
tion of hyperphenylalaninemia in clinical malaria [18] and to assess the relationship between
systemic BH4 status and plasma phenylalanine concentration. Hyperphenylalaninemia (upper
limit of normal in children age> 12 months, 80uM; upper limit of normal in children age<
12 months, 100 uM) was found in 4 (3.7%) of 109 HC, 44 (72.1%) of 61 UM, 40 (80%) of 50
CM, and 23 (45.1%) of 51 NMC. Plasma phenylalanine concentrations differed significantly
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across all groups (Table 2). This association remained after using linear regression to control
for age, weight, and fasting duration. Using the same linear regression model, plasma phenylal-
anine concentrations differed significantly in CM compared to UM (p = 0.04), and across UM,
CM survivors and CM fatalities (p = 0.015). Plasma phenylalanine concentration correlated
with urine BH2 concentration among HC (r = 0.29; p = 0.002), UM (r = 0.43; p = 0.001), and
NMC (r = 0.32; p = 0.03), but among CM the correlation was non-significant (r = 0.22; p =
0.15). Similarly, when analyzing UM and CM children jointly, there was a significant correla-
tion between plasma phenylalanine and BH2 was observed (r = 0.38; p<0.001), but we when
employed a partial correlation test to control for malaria disease severity, this correlation was
non-significant (r = 0.17; p = 0.09). Plasma phenylalanine did not correlate with BH4 or the
BH4/BH2 ratio. Despite a non-significant correlation among CM, overall we found a moderate
correlation between plasma phenylalanine and urine BH2 levels, a result that is consistent with
the body of literature demonstrating the ability of BH2 to inhibit PAH enzymatic conversion of
phenylalanine to tyrosine [28].
Bivariate and multivariate regression analysis correlating urine BH4 to
severity of malaria
In bivariate logistic regression among all malaria patients (Table 3), a unit decrease in Log10-
urine BH4 and Log10-urine BH4/BH2 ratio was associated with 2.94-fold (95% CI 1.65–5.23) in-
crease and 3.29-fold (95% CI 1.87–5.76) increase, respectively, in the odds of CM (p<0.001). A
unit increase in log10-urine BH2 was associated with a 1.91-fold increase (95% CI 0.99–3.67) in
the odds of CM (p = 0.04). In the backward stepwise multivariate logistic regression model for
risk of CM, variables were retained in the model if their p-value was< 0.2. The final model in-
cluded urine BH4, urine BH2, P. falciparum histidine-rich protein-2 (PfHRP-2), respiratory
Fig 4. Plasma angiopoietin-2 concentrations at enrollment in the 4 clinical groups. Comparison of
plasma angiopoietin-2 (Ang-2) concentrations at enrollment in a subset of healthy controls (HC, n = 9),
uncomplicated malaria (UM, n = 10), cerebral malaria (CM, n = 16) and non-malaria central nervous system
conditions (NMC, n = 9) (p<0.001 by Kruskal-Wallis). The central line indicates median. Upper and lower
lines indicate inter-quartile range.
doi:10.1371/journal.ppat.1004655.g004
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rate and weight (Table 3). Urine BH4 and urine BH2 levels were independently associated with
odds of CM: a unit decrease in Log10-urine BH4 was associated with 3.85-fold (95% CI 1.89–
7.61) increase in the odds of CM (p<0.001). Note that as Table 3 models risk of CM for every
unit increase in a given variable, the inverse is displayed—i.e., a unit increase in Log10-urine
BH4 was associated with 0.26-fold (95% CI 0.13–0.53) decrease in odds of CM [p<0.001]. A
unit increase in Log10-urine BH2 was associated with a 2.86-fold (95% CI 1.01–8.07) increase
in the odds of CM (p = 0.047).
The urine BH4:BH2 ratio is not included in the logistic regression model due to co-linearity
with BH4. When the multivariate model included the BH4:BH2 ratio in lieu of urine BH4, the
odds ratio of CM was comparable to the odds ratio of CM seen with urine BH4: a unit decrease
in Log10-urine BH4:BH2 ratio was associated with a 3.63-fold (95% CI 1.95–6.72) increase in
the odds of CM (p<0.001).
Discussion
Systemic BH4 concentrations are significantly lower in children with CM compared to HC,
UM, and NMC. BH4 concentrations were likewise significantly lower in fatal CM when com-
pared across the spectrum of UM and CM survivors, and a decrease in urine BH4 was indepen-
dently associated with a 3.85-fold increase in odds of CM. While two prior studies reported
conflicting results on BH4 levels in cerebrospinal fluid [17,49], our study is the first published
analysis of systemic biopterin levels in severe human malaria. Our findings have important im-
plications regarding the underlying reasons for the decreased NO bioavailability and microvas-
cular dysfunction observed in severe malaria [16,19,21]. These data also represent a novel link
between the extensive vascular medicine research regarding the effects of BH4 and BH2 on the
endothelium [27] and the vasculopathic mechanisms of severe malaria [16].
Table 3. Bivariate and multivariate logistic regression analysis of factors associated with increased odds of cerebral malaria.
Variable N Bivariate OR (95% CI) p-value Multivariate OR (95% CI) p-value
Urine BH4 100 0.34 (0.19–0.60) <0.001 0.26 (0.13–0.51) <0.001
Urine BH2 100 1.91 (0.99–3.68) 0.053 3.38 (1.24–9.21) 0.018
Phenylalanine 111 1.78 (0.89–3.55) 0.101 — >0.05A
PfHRP-2 106 1.26 (1.03–1.53) 0.024 — >0.05
Hemoglobin 116 0.73 (0.60–0.89) 0.001 — >0.05A
Bicarbonate 79 1.03 (0.95–1.11) 0.480 — —B
Respiratory Rate 118 1.07 (1.04–1.17) 0.001 1.10 (1.05–1.17) <0.001
Weight 118 1.09 (0.98–1.21) 0.106 1.19 (1.02–1.39) 0.026
Age 118 1.02 (1.00–1.05) 0.038 — >0.05A
Sex 118 1.67 (0.79–3.54) 0.181 — —B
Last meal 118 0.99 (0.94–1.07) 0.99 — >0.05A
CI = conﬁdence intervals
BH4 = tetrahydrobiopterin
BH2 = dihydrobiopterin
PfHRP-2 = P. falciparum histidine-rich protein-2
Note: Phenylalanine, Urine BH4, Urine BH2 and PfHRP-2 were log-transformed to enable regression analysis. Number of observations included in
multivariate model was 96.
A = included in multivariate logistic regression analysis, but not retained in the ﬁnal model due to p-value > 0.05 in multivariate analysis.
B = not included in multivariate logistic regression analysis because of non-signiﬁcance in bivariate logistic regression analysis.
doi:10.1371/journal.ppat.1004655.t003
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Our prior studies have demonstrated that NO is important in protecting against severe ma-
laria, including CM, and have demonstrated several mechanisms by which NO bioavailability
is decreased in malaria. These mechanisms include: low overall NO production [21]; low
NOS2 protein levels in peripheral blood mononuclear cells [21]; low NOS activity in PBMC
[22]; NOS2 single nucleotide polymorphisms that modulate NO production [23]; increased
cell-free hemoglobin, an NO quencher [50]; decreased NOS substrate arginine [6,24]; and in-
creased asymmetric dimethyl arginine (ADMA) [25,26], an endogenous inhibitor of NOS ac-
tivity [51]. Our present study documents another potential mechanism for low NO production
in severe malaria—diminished levels of NOS cofactor, BH4. Our prior studies of NO in malaria
have focused on NOS2 (inducible NOS), which is expressed in multiple tissues, including brain
and endothelium. Our current findings apply not only to NOS2, but to all three NOS isoforms
(endothelial, inducible and neuronal), as BH4 is an obligate co-factor for all three NOS iso-
forms and deficiency of BH4 can result in diminished NOS activity and cause uncoupling in all
NOS isoforms. We observed that total urine biopterins (which reflect total body biopterins)
were increased in mild and severe malaria. Expression of PBMC mRNA for CGH1, the rate-
limiting enzyme in biopterin synthesis, was at least as high in malaria as in HC. While pterin
synthesis in human leukocytes may not reflect biopterin bioavailability in other tissues (e.g.,
the endothelium), this finding is consistent with our observation of increased total urine biop-
terins in malaria. Beyond the absolute totals, we think the more significant observation is the
markedly skewed distribution of biopterin species in CM cases—we found that nearly 2/3 of
biopterins were oxidized to inactive forms, a finding not previously reported. Tanzanian chil-
dren with CM had significantly lower urine BH4 concentrations and a lower BH4:BH2 ratio
compared to HC, UM and NMC.
Quantification of the different redox states of biopterins in malaria—fully reduced, BH4,
and its oxidized metabolites, BH2 and B0—may be a novel method for measuring oxidative
stress in severe malaria and possibly other critical illnesses. The same rationale applies to the
NH2:N0 ratio. Our finding of increased levels of neopterin in UM and CM is consistent with
prior reports of neopterin concentrations in malaria [52,53]. While the pathophysiologic role
of neopterin remains unclear, the ratio of reduced to oxidized neopterin (NH2:N0) might repre-
sent a novel parameter to quantify mononuclear phagocyte redox state. The decrease in both
BH4:BH2 and NH2:N0 ratios indicates increased systemic oxidative stress in CM.
As a NOS co-factor, BH4 performs both structural and biochemical functions. It stabilizes
the NOS homodimer, thereby enabling NOS catalytic function, and it donates an electron to
form a transient BH4∙
+ radical which is required for oxidation of L-arginine to L-citrulline [27].
However, in the absence of BH4, NOS catalyzes a reaction in which NADPH-derived electrons
reduce heme iron thereby binding and activating oxygen [54]. Without BH4-dependent L-argi-
nine oxidation, activated oxygen is released from the heme catalytic center of NOS as superox-
ide. This generation of superoxide is termed NOS “uncoupling,” as L-arginine oxidation to L-
citrulline is no longer coupled to oxygen activation for NO synthesis and release [27]. In an en-
vironment where both superoxide (uncoupled NOS) and NO (coupled NOS) are generated,
both products may react to yield peroxynitrite [55,56]. Peroxynitrite and superoxide induce
further uncoupling by oxidizing available BH4 to BH2 [57], thereby decreasing the availability
of BH4 for NO synthesis. This uncoupling is compounded by BH2 accumulation, which com-
petes with BH4 at its NOS binding site, further inhibiting NOS-catalyzed NO synthesis [37].
Thus a feed-forward mechanism, initiated by low intracellular BH4 levels, ensues and leads to
oxidative injury caused by superoxide and peroxynitrite [58]. Experimental models of eNOS
activity indicate that the BH4:BH2 ratio, which we found to be significantly decreased in CM
compared to all other groups, is the measurement that most strongly correlates with NOS un-
coupling [37].The hyperphenylalaninemia that we previously described in UM and CM [18]
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was one of the initial observations that led us to test the hypothesis of impaired BH4 in CM,
since BH4 is an essential cofactor for the enzymatic hydroxylation of phenylalanine to tyrosine.
We confirmed our prior finding of elevated plasma phenylalanine in UM and CM. Our present
findings suggest that this elevation in malaria is secondary to decreased systemic concentra-
tions of BH4 and increased concentrations of BH2.
Decreased BH4 and increased BH2 systemic levels in children with CMmay be relevant to
the central pathogenic mechanisms in severe malaria—endothelial activation and dysfunction
and the sequestration of pRBCs, unparasitized RBCs, mononuclear cells, and platelets resulting
in microcirculatory congestion of post-capillary venules [14,16,19,59]. Endothelial cells low in
intracellular BH4 and high in BH2 favor decreased NO production by NOS, and low NO syn-
thesis is associated with endothelial dysfunction [6]. The effect of decreased NO production
due to NOS uncoupling may exacerbate microvascular sequestration in several ways. Low NO
states are associated with decreased RBC deformability [60]. In vitro endothelial cell models
have shown that increased bioavailability of NO is associated with decreased cytoadherence of
P. falciparum-infected RBCs via down-regulation of endothelial receptors for P. falciparum
erythrocyte membrane protein [61,62]. NO deficiency causes increased vascular tone with de-
creased vessel diameter and possible flow impedance. Additionally, NOS uncoupling due to
low BH4 and high BH2 would also favor generation of peroxynitrite, a highly reactive species
thought to exacerbate endothelial cell dysfunction [63]. Given that low BH4 levels may be con-
tributing to endothelial dysfunction and sequestration in severe malaria, adjunctive therapy to
reduce BH2 and regenerate BH4 warrants further study [64,65]. The need for such studies is
also supported by an experimental animal model of cerebral malaria demonstrating that the
blunted cerebral arteriolar response to NOS agonists is partially recovered by supplementation
with BH4 [66].
While our study has many strengths, including rigorous case definitions for the four clinical
groups and rigorous methods for sample collection, processing and analysis, we acknowledge
several limitations. The specificity of the WHO case definition for CMmay be as low as 77%
[13]. The causes and severity of illness in the NMC group were heterogeneous, making com-
parisons with this group more tenuous. Since we were able to measure plasma creatinine in
only 16 UM and 39 CM patients, we did not include plasma creatinine in the final multivariate
logistic regression model assessing for an independent association between urine BH4 concen-
trations and malaria severity. We therefore cannot exclude that the significant association be-
tween BH4 and malaria severity is dependent upon renal function. We performed a
multivariate logistic regression sub-model for the 48 malaria patients who had urine biopterin
and plasma creatinine results. In this sub-model we found that only respiratory rate (OR 1.11
[95% CI 1.01–1.21]; p = 0.04) and plasma creatinine (OR 201.42 {95% CI 8.15–4978.96]; p =
0.001) were independently associated with odds of cerebral malaria (BH4 OR 0.34 [95% CI
0.09–1.28;p = 0.11). This indicates that plasma creatinine has a statistically significant associa-
tion with malaria severity, but the wide confidence intervals show a lack of power for more pre-
cisely assessing this relationship and its impact on the association between urine BH4 and
malaria severity. While the lack of plasma creatinine results is a key limitation of our final mul-
tivariate logistic regression model, we note the following in regards to the urine BH4 measure-
ments and renal function: 1) only two children (both with CM) had clinically significant renal
impairment; 2) A linear regression model of urine BH4 showed no significant variance by plas-
ma creatinine among the 85 children in whom both a urine BH4 measurement and a plasma
creatinine measurement. 3) Total urine biopterins were increased in CM patients, which argues
against the higher mean plasma creatinine values in CM as accounting for the decreased levels
of BH4 in the urine of CM patients. Inclusion of plasma creatinine in the model would have
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been optimal, but the reasons detailed above, we think exclusion of creatinine from the multi-
variate logistic regression model is justified and preferred.
Additional limitations include the fact that we did not measure NO bioavailability directly
and that our findings do not demonstrate a causal link between endothelial cell dysfunction
and low systemic BH4. Unlike our companion study demonstrating decreased systemic BH4 in
Indonesian adults with severe falciparum malaria, we do not have measures of endothelial
function in this study to compare with the decreased levels of systemic BH4 we have observed
in Tanzanian children with CM. Among a subset of the cohort we were able to measure Ang-2,
a mediator of endothelial cell activation that is associated with reduced NO-bioavailability in
both severe malaria and sepsis [10,67]. The markedly elevated plasma Ang-2 levels and the ab-
normal urine biopterin metabolite levels observed among children with malaria were not sig-
nificantly correlated. A small sample size may have limited our ability to show a significant
correlation between Ang-2 and BH2. While we speculate that the highly perturbed BH4: BH2
ratio is due to oxidative stress, we do not have additional purported measures of oxidative
stress with which to compare biopterin redox status. An alternative explanation for this the low
BH4: BH2 ratio is impaired recycling via DHFR conversion of BH2 to BH4.
In conclusion, we found that BH4, an essential cofactor for NO production, is low in chil-
dren with CM, and that low BH4 concentrations are independently associated with disease se-
verity in children with malaria. Low BH4 may contribute to the pathogenesis of severe malaria
as it represents an important mechanism of low NO bioavailability. Furthermore, low BH4 to-
gether with elevated BH2 likely leads to generation of reactive oxygen species. These potential
sequelae of low systemic BH4 likely contribute to endothelial dysfunction and pRBC sequestra-
tion—hallmark pathophysiologic features of severe malaria. Interventions that replenish BH4
or redistribute the BH4:BH2 ratio toward reduced BH4 merit investigation as adjunctive thera-
pies to improve outcomes in pediatric severe falciparum malaria.
Materials and Methods
Study design and site
We conducted a prospective observational study in Dar es Salaam, Tanzania. Children were en-
rolled from the clinics and the inpatient wards of Amana and Mwanayamala District Hospitals
into the following four groups: UM, CM, NMC (see criteria below), and HC. These two district
hospitals are separated by 6.5 kilometers, and both are located in semi-urban areas of Dar es
Salaam. Once enrolled, children with CM or with NMC were transferred to the clinical re-
search unit at the Hubert Kairuki Memorial University Hospital for further evaluation and
care. Approval for this study was obtained from the institutional review boards of Hubert Kair-
uki Memorial University, United Republic of Tanzania National Medical Research Institute,
University of Utah, and Duke University. Informed consent was obtained from parents or
guardians of all children, and the U.S. Department of Health and Human Services guidelines
for human subjects research were followed.
Enrollment criteria
Children were 6 months to 6 years in age. The World Health Organization (WHO) case defini-
tion for CM was used as the inclusion criteria for the CM cohort: any level of P. falciparum
parasitemia on peripheral blood smear; unarousable coma (Blantyre Coma Score 2) not at-
tributable to hypoglycemia (blood glucose level< 40 mg/dL) and persisting more than 60 min-
utes after any convulsion; no other identifiable cause of coma [68]. Inclusion criteria for UM
were as follows: a clinical syndrome consistent with malaria and a documented fever (tempera-
ture 38° C) or history of fever within 48 hours from time of enrollment; P. falciparum
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parasitemia> 10,000 parasites/μL on Giemsa-stained blood film plus a positive P. falciparum
RDT (Paracheck-Pf; Omega Diagnostics); no other cause of fever identified; no WHO warning
signs suggestive of severe disease [68]. These warning signs were the following: inability to
suckle, eat and/or drink; excessive vomiting; abnormal respiratory rate or respiratory distress
as evidenced by accessory muscle use, suprasternal retractions, or intercostal retractions; recent
history of convulsions; altered mental status; inability to sit unaided.
Exclusion criteria for both groups with malaria were any of the following: microscopic evi-
dence of mixed infection with any other Plasmodium species; bacterial co-infection as evi-
denced by septicemia or urinary tract infection; oral or intravenous quinine or oral artemesinin
combination therapy initiated> 18 hours prior to enrollment; hemoglobin< 5 mg/dL, as
erythrocyte transfusions were not readily available at our study sites. Children with CM were
excluded if they had evidence of bacterial meningitis as indicated by isolation of a pathogen
from CSF culture or by CSF analysis.
Similar aged healthy children and children presenting with NMC were prospectively en-
rolled as control groups. The healthy children were enrolled from outpatient well-baby clinics
at the two district hospitals. Eligible children had no signs or symptoms of active illness, no fe-
brile illness within the previous two weeks, no history or evidence of an active inflammatory
condition, and negative P. falciparum RDT (Paracheck-Pf; Omega Diagnostics). Children with
NMC were eligible if they had a CNS condition for which a lumbar puncture for CSF analysis
was clinically indicated as part of diagnostic evaluation and management (e.g. suspected men-
ingitis, encephalitis, hemorrhage, trauma, metabolic, toxic, recurrent seizures as cause for al-
tered mental status). All children enrolled in this group had a Giemsa-stained blood film
negative for Plasmodium and a negative P. falciparum RDT (Paracheck-Pf; Omega Diagnos-
tics). A subset of children in this group were classified as likely bacterial or fungal meningitis
based on detection of a microbiologic pathogen in CSF and one of the following findings on
CSF analysis: white blood cell count> 6/μL, neutrophils present on cytospin Wright stain
prep, or glucose< 2/3 plasma glucose level.
Clinical evaluation and management
At presentation, demographic information, clinical history, and examination were documented
using standardized case report forms. Capillary blood samples were obtained for Giemsa-
stained thick and thin blood films as well as on-site malaria rapid diagnostic testing. Venous
samples for routine laboratory analysis included complete blood count (Beckman-Coulter Act
10), sodium, potassium, chloride, bicarbonate, blood urea nitrogen, creatinine, and venous
blood gas (i-STAT 1; Abbott Laboratories). Urine collected for pterin quantification (see
below) was also subjected to urine dipstick analysis (Multistix 10 SG; Siemens Healthcare Diag-
nostics) and urine culture. These blood and urine laboratory results were immediately available
to the clinician. Blood cultures were obtained in all children with UM and CM to rule out con-
comitant bacteremia. Lumbar puncture with opening pressure measurement was done in all
patients with coma to evaluate for meningitis. CSF analysis included determination of glucose
and protein levels, cell count with differential by trained microscopists, and bacterial and
fungal cultures.
Children with UM and CM received anti-malarial therapy and other supportive care as per
standard Tanzanian national protocols at the time of the study (artemesinin combined oral
therapy and intravenous quinine, respectively). Treatment was initiated as soon as the diagno-
sis of malaria was suspected. Children with CM and NMC were re-examined daily until death
or hospital discharge.
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Urine collection and storage
Urine was collected from subjects at the time of enrollment. Strict adherence to the collection
procedure was followed in every case. All collection and handling of urine samples was done in
the dark or under dim lighting (collection bags covered with a black, light-impermeable cloth)
to prevent photo-oxidation. For quantification of urine biopterins and neopterins, 5–20 ml
urine was collected voluntarily into a sterile urine collection cup or with use of a pediatric bag
(U-bag urine collector, Hollister Pediatric) affixed to the perineum with adhesive. In both
cases, issuing urine was immediately collected into solid dithioerythritol (DTE, approximately
50 mg/ml urine) and diethylene triamine penta-acetic acid (DETAPAC, approximately 5 mg/
ml urine) and mixed well to dissolve the powders as described previously [35]. Immediately
after collection, urine samples were placed into an insulated transport cooler charged with
large cooling packs preconditioned at -80° C. This resulted in freezing of urine samples within
minutes. The samples were then stored in a -80° C freezer and then transported to the USA in
a liquid nitrogen dry shipper, and subsequently stored at -80° C until pterin analysis. This pro-
cedure exceeded in stringency the conditions required to prevent oxidation of reduced pterins
previously described [35,69]. Reagent BH4 exposed to this procedure was stable at concentra-
tions in the range measured on clinical urine samples; no detectable oxidation of BH4 measured
by our analytic methods occurred. Conversely, exposure of oxidized reagent pterins to this pro-
cedure did not result in any measureable reduction. Thus the analysis of our samples revealed
quantities of urine pterins as they existed in vivo.
Quantification of urine pterins
Thawed urine samples were mixed and directly subjected to analysis for BH4, BH2 and B0 and
for NH2 and N0 by high-performance liquid chromatography (HPLC) using sequential electro-
chemical and fluorescence detection. The procedure relies on reversed phase HPLC separation
of pterins, BH4, BH4, NH2, B0 and N0 in samples of urine. BH4 is oxidized to quinonoid dihy-
drobiopterin (q-BH2) and then reduced back to BH4. The current generated on the reduction is
monitored and used to determine BH4 concentration using an ESA Coularray electrochemical
integration system. BH2 and NH2 are oxidized to B0 and N0 respectively by electrochemistry
and then measured by fluorescence using EZ Chrom integration system. B0 and N0 are not af-
fected by electrochemical electrodes and are measured by their natural fluorescence using the
EZ Chrom system. Further details of the analytical methods are as reported previously [70]
(see S2 Fig. and see Fig. 2 & 3 in citation 41 for example chromatograms).
Plasma PfHRP-2 measurement
PfHRP-2, a measure of total parasite biomass, was quantified by ELISA as previously described
[6,10] using primary and secondary monoclonal antibodies to P. falciparumHRP-2 (MPFM-
55A and MPFG-55P; Immunology Consultant Laboratories). Concentrations were derived
from standard curves utilizing purified PfHRP-2 kindly provided by D. Sullivan (Johns Hop-
kins University School of Public Health). Samples with ODs outside the linear part of the curve
were repeated at an appropriate dilution until an accurate concentration was determined. The
lower limit of detection was 1.5 ng/mL.
Plasma Angiopoietin-2 measurement
Ang-2 was measured by ELISA (R&D Systems) as noted before [10].
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Measurement of mRNA for GTPCH-1 by qRT-PCR
PBMC were isolated using standard methods. RNA was extracted from PBMC and subjected
to real-time reverse transcriptase-polymerase chain reaction (RT-PCR) techniques. We used
the equivalent of 100 ng RNA per reaction. Stratagene VILO kit was used for the RT reaction,
and the Roche faststart universal probe master kit for PCR (Roche Applied Science). Primer/
probe sets were designed by the Roche universal probe library application. Primers were then
made by IDT while probes were from the Roche universal probe library (http://
universalprobelibrary.com) (Roche Applied Science). The quantitative PCR were performed]
on an ABI7300 machine. Samples were run in triplicate, or in duplicate if sample amount was
limiting. The GAPDH and HPRT1 genes were selected as endogenous control genes. The aver-
age Ct of the endogenous controls for each sample was used in the dCt calculation. For individ-
ual ddCt values, we used each sample dCt and the averaged healthy control dCt. For group
ddCt values, we used the average dCt for each group to calculate ddCt for the group. The data
is expressed as 2-ddCt, which is the fold change as compared to the average of the healthy con-
trols. Table 4 displays the relevant sequences for the primers and probes.
Plasma amino acid analysis
Blood samples were collected into heparin tubes, mixed and immediately centrifuged to sediment
blood cells. Supernatant plasma was removed to freezing tubes and placed into the transport ves-
sel described above, after which they were stored at -80° C until thawing for analysis. Amino
acids were quantified by ion-exchange chromatography with detection using spectrophotometry
after reaction with ninhydrin. All amino acid analysis was performed at the Biochemical Genetics
Section, ARUP Laboratories, University of Utah in collaboration with Dr. Marzia Pasquale.
Statistical methods
Statistical analysis was performed with STATA software (version 12.0; StataCorp). Results are
presented as mean with 95% confidence intervals for normally distributed continuous variables
or median with interquartile range for variables with non-parametric distribution. For continu-
ous variables with normal distribution, differences across groups were compared by ANOVA
with Bonferroni adjustment for multiple comparisons and differences between groups were
compared using Student’s t-test. For continuous variables with a non-parametric distribution,
differences across groups were compared using Kruskal-Wallis test and differences between
groups were compared using the Wilcoxon rank-sum test. Correlation between variables with
non-parametric distributions was assessed using Spearman correlation coefficients, and we
used the partial correlation test to assess for correlations while controlling for malaria severity.
Differences in proportions between groups were assessed with Chi-square test. Multivariate
linear regression was used to control for confounding variables that could affect urine BH4 and
plasma phenylalanine concentrations. Bivariate logistic regression was used to analyze continu-
ous variables for co-variation by a binomial variable (e.g., co-variation of urine BH4 concentra-
tion by the presence or absence of pyuria). For children with UM and CM, backward stepwise
Table 4. Primers and probes for GTP-cyclohydrolase I mRNA reverse transcriptase polymerase chain reaction.
Gene Forward Primer Reverse Primer Probe number Probe cat# Probe sequence
GTPCH1 gctgtagcaatcacggaagc cacctcgcattaccatacaca 67 4688660001 tgctggag
GAPDH agccacatcgctcagacac gcccaatacgaccaaatcc 60 4688589001 tggggaag
HPRT1 tgaccttgatttattttgcatacc cgagcaagacgttcagtcct 73 4688961001 gctgagga
doi:10.1371/journal.ppat.1004655.t004
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multivariate logistic regression was performed to determine whether phenylalanine or urine
biopterin species were independently associated with disease severity. Bivariate logistic regres-
sion was performed for available biologically plausible variables known to be associated with
severe malaria: hemoglobin, PfHRP-2, and respiratory rate and bicarbonate, as indicators of
metabolic acidosis [3,71,72]. Variables were included in the multivariate logistic regression
model if p< 0.20 on bivariate analysis, and were retained in the multivariate model if the p-
value generated in the multivariate analysis was<0.05. The multivariate model also controlled
for age, sex, weight and duration of fasting. Plasma creatinine was not included in the multivar-
iate model because creatinine results were only available for 14 UM and 34 CM patients with
urine biopterin results. In a multivariate logistic regression sub-model of these 48 malaria pa-
tients we did include creatinine in order to assess the relationship between estimated renal
function and odds of cerebral malaria. Continuous variables with non-parametric distributions
were log-transformed to meet normality assumptions for use in the logistic regression models.
Goodness-of-fit was assessed by Hosmer-Lemeshow test. A two-sided p-value of< 0.05 was
employed as the cut-off for statistical significance throughout the manuscript unless otherwise
indicated (e.g., Bonferoni adjustments when making comparisons across multiple groups).
Supporting Information
S1 Fig. Scatterplot correlation of plasma Angiopoeitin-2 and urine dihydrobiopterin. Plas-
ma Angiopoeitin-2 (Ang-2) plotted against urine dihydrobiopterin (BH2). Squares represent
healthy controls (HC, n = 9), triangles represent uncomplicated malaria (UM, n = 5), circles
represent cerebral malaria (CM, n = 13), and stars represent non-malaria central nervous sys-
tem conditions (NMC, n = 9).
(TIF)
S2 Fig. Representative chromatograms of biopterin and neopterin analytes. A: Electro-
chemical detection of of tetrahydrobiopterin (BH4) and dihydroneopterin (NH2) in urine. B:
Electrochemical detection of BH4 and NH2 in standards. C: Fluorescence detection of neop-
terin (N0), dihydroneopterin (NH2), biopterin (B0), and dihydrobiopterin (BH2) in urine.D:
Fluorescence detection of N0, NH2, B0, and BH2 in standards.
(TIF)
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